Bupropion Hydrochloride
- Product NDC
- 71335-0331
- 11-digit product format
- 713350331
- Labeler code
- 71335
- Product ID
- 71335-0331_f9f011ce-447f-4239-b2b3-538b3a7e9e34
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA077285
- Marketing category
- ANDA
- Marketing start
- 2015-02-17
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0331-1 | 71335033101 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0331-1) | 2015-06-24 | 0000-00-00 | No | No | Current |
| 71335-0331-2 | 71335033102 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0331-2) | 2015-06-24 | 0000-00-00 | No | No | Current |
| 71335-0331-3 | 71335033103 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0331-3) | 2015-06-24 | 0000-00-00 | No | No | Current |
| 71335-0331-4 | 71335033104 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0331-4) | 2015-06-24 | 0000-00-00 | No | No | Current |
| 71335-0331-5 | 71335033105 | 8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0331-5) | 2015-06-24 | 0000-00-00 | No | No | Current |